Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$205.27 USD
+3.94 (1.96%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $205.42 +0.15 (0.07%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CRL 205.27 +3.94(1.96%)
Will CRL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRL
Why Charles River (CRL) International Revenue Trends Deserve Your Attention
Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings
Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates
Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
Other News for CRL
UK shareholder meetings calendar - next 21 days
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 21 days
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 21 days